NORTH AMERICA VETERINARY VACCINES MARKET FORECAST 2020-2028

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA VETERINARY VACCINES MARKET FORECAST 2020-2028

NORTH AMERICA VETERINARY VACCINES MARKET FORECAST 2020-2028

 The North America veterinary vaccines market is anticipated to record a CAGR of 6.01% over the estimated period, 2020-2028. Significant advancement in the production of vaccine technology, especially the rabies vaccine, is a major factor driving the growth of the market. In order to survey the North America veterinary vaccines market, the region is surveyed through the market regions of the US and Canada.

NORTH AMERICA VETERINARY VACCINES MARKET FORECAST 2020-2028

North America Veterinary Vaccines Market by Vaccine Type (Livestock Vaccine (Porcine Vaccine, Bovine Vaccine, Poultry Vaccine, Aquaculture Vaccine, Other Livestock Vaccine), Companion Vaccine (Canine Vaccine, Feline Vaccine, Equine Vaccine)) by Technology (Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, Toxoid Vaccine, Other Technology) by Disease (Canine Disease, Porcine Disease, Bovine Disease, Poultry Disease, Aquaculture Disease, Other Disease Type) by Geography.

Request free sample

The North America veterinary vaccines market is anticipated to record a CAGR of 6.01% over the estimated period, 2020-2028. Significant advancement in the production of vaccine technology, especially the rabies vaccine, is a major factor driving the growth of the market.

In order to survey the North America veterinary vaccines market, the region is surveyed through the market regions of the US and Canada. In the US, veterinary vaccines are regulated by the Centre for Veterinary Biologics in the Animal and Plant Health Inspection Service. The CVB grants building and product licenses to animal health companies, to manufacture and sell veterinary biologic drugs. FDA has no participation in determining vaccines for diseases occurring in animals. Vaccination in wildlife and companion animals for zoonotic diseases had a considerable impact in decreasing the occurrence of zoonotic diseases in people. Livestock vaccines are used to improve the efficiency of the production of animals, raised to be consumed as food. Wildlife vaccines are used for zoonotic diseases, for instance, vaccines for rabies. The Brucella Abortus Eradication Program in the US promoted vaccines that were instrumental for Brucellosis. The factors boosting the US veterinary vaccines market are safe animal food supply, awareness for the prevention of animal to human transmission diseases, and as compared to human vaccines, lower investment in R&D in animal vaccines.

Elanco, headquartered in Indianapolis, Indiana, the US, is a global animal health division of Eli Lily and Company. It has a business presence in Japan, Europe, the US, and other countries. It operates in two divisions, namely human pharmaceutical products and animal health products.In Jan 2020, Lily acquired Dermira, and this acquisition also includes QBREXZA.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARIES
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    • KEY DRIVERS
      • PROGRESSION IN THE VACCINE PRODUCTS
      • INCREASING GOVERNMENT INITIATIVES
      • INCREASING INCIDENCE OF ZOONOTIC DISEASES
      • SURGE IN THE COMPANION ANIMAL OWNERSHIP
      • GROWING PREVALENCE OF LIVESTOCK DISEASES
    • KEY RESTRAINTS
      • HIGH COST OF VACCINATIONS
      • SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
      • LACK OF SKILLED FARMWORKERS AND VETERINARIANS
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY VACCINE TYPE
    • LIVESTOCK VACCINE
      • PORCINE VACCINE
      • BOVINE VACCINE
      • POULTRY VACCINE
      • AQUACULTURE VACCINE
      • OTHER LIVESTOCK VACCINE
    • COMPANION VACCINE
      • CANINE VACCINE
      • FELINE VACCINE
      • EQUINE VACCINE
  1. MARKET BY TECHNOLOGY
    • LIVE ATTENUATED VACCINE
    • INACTIVATED VACCINE
    • RECOMBINANT VACCINE
    • TOXOID VACCINE
    • OTHER TECHNOLOGY
  2. MARKET BY DISEASE TYPE
    • CANINE DISEASE
    • PORCINE DISEASE
    • BOVINE DISEASE
    • POULTRY DISEASE
    • AQUACULTURE DISEASE
    • OTHER DISEASE TYPE
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPANY PROFILES
    • ANICON LABOR GMBH
    • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
    • CEVA SANTE ANIMALE
    • ELANCO (ELI LILLY AND COMPANY)
    • HESTER BIOSCIENCES LIMITED
    • HIPRA
    • HYGIEIA BIOLOGICAL LABORATORIES
    • MERCK & CO.
    • PHIBRO ANIMAL HEALTH CORP.
    • ROMVAC COMPANY S.A.
    • VAXXINOVA GMBH-GERMANY
    • VIRBAC SA
    • ZOETIS ANIMAL HEALTHCARE

 

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – VETERINARY VACCINE

TABLE 2: NORTH AMERICA VETERINARY VACCINES, BY VACCINE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: NORTH AMERICA VETERINARY VACCINES, BY VACCINE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: NORTH AMERICA LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA PORCINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: COMMERCIALLY AVAILABLE PORCINE VACCINES

TABLE 10: NORTH AMERICA PORCINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 11: NORTH AMERICA BOVINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 12: COMMERCIALLY AVAILABLE BOVINE VACCINES

TABLE 13: NORTH AMERICA BOVINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 14: NORTH AMERICA POULTRY VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 15: COMMERCIALLY AVAILABLE POULTRY VACCINES

TABLE 16: NORTH AMERICA POULTRY VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 17: NORTH AMERICA AQUACULTURE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 18: COMMERCIALLY AVAILABLE AQUACULTURE VACCINES

TABLE 19: NORTH AMERICA AQUACULTURE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 20: NORTH AMERICA OTHER LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 21: NORTH AMERICA OTHER LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 22: NORTH AMERICA COMPANION VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 23: NORTH AMERICA COMPANION VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 24: NORTH AMERICA COMPANION VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 25: NORTH AMERICA COMPANION VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 26: NORTH AMERICA CANINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 27: COMMERCIALLY AVAILABLE CANINE VACCINES

TABLE 28: NORTH AMERICA CANINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 29: NORTH AMERICA FELINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 30: COMMERCIALLY AVAILABLE FELINE VACCINES

TABLE 31: NORTH AMERICA FELINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 32: NORTH AMERICA EQUINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 33: COMMERCIALLY AVAILABLE EQUINE VACCINES

TABLE 34: NORTH AMERICA EQUINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 35: NORTH AMERICA VETERINARY VACCINES, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 36: NORTH AMERICA VETERINARY VACCINES, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 37: NORTH AMERICA LIVE ATTENUATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 38: NORTH AMERICA LIVE ATTENUATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 39: NORTH AMERICA INACTIVATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 40: NORTH AMERICA INACTIVATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 41: NORTH AMERICA RECOMBINANT VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 42: NORTH AMERICA RECOMBINANT VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 43: NORTH AMERICA TOXOID VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 44: NORTH AMERICA TOXOID VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 45: NORTH AMERICA OTHER TECHNOLOGY MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 46: NORTH AMERICA OTHER TECHNOLOGY MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 47: NORTH AMERICA VETERINARY VACCINES, BY DISEASE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 48: NORTH AMERICA VETERINARY VACCINES, BY DISEASE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 49: NORTH AMERICA CANINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 50: NORTH AMERICA CANINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 51: NORTH AMERICA PORCINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 52: NORTH AMERICA PORCINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 53: NORTH AMERICA BOVINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 54: NORTH AMERICA BOVINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 55: NORTH AMERICA POULTRY DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 56: NORTH AMERICA POULTRY DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 57: NORTH AMERICA AQUACULTURE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 58: NORTH AMERICA AQUACULTURE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 59: NORTH AMERICA OTHER DISEASE TYPE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 60: NORTH AMERICA OTHER DISEASE TYPE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 61: NORTH AMERICA VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 62: NORTH AMERICA VETERINARY VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

 

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: NORTH AMERICA VETERINARY VACCINES, BY VACCINE TYPE, IN 2019

FIGURE 5: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 6: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 7: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA COMPANION VACCINE MARKET, BY CANINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA COMPANION VACCINE MARKET, BY FELINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA VETERINARY VACCINES, BY TECHNOLOGY, IN 2019

FIGURE 16: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 20: NORTH AMERICA VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA VETERINARY VACCINES, BY DISEASE TYPE, IN 2019

FIGURE 22: NORTH AMERICA VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 23: NORTH AMERICA VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 25: NORTH AMERICA VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 26: NORTH AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 27: NORTH AMERICA VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2020-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 29: THE UNITED STATES VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 30: CANADA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY VACCINE TYPE
    • LIVESTOCK VACCINE
      • PORCINE VACCINE
      • BOVINE VACCINE
      • POULTRY VACCINE
      • AQUACULTURE VACCINE
      • OTHER LIVESTOCK VACCINE
    • COMPANION VACCINE
      • CANINE VACCINE
      • FELINE VACCINE
      • EQUINE VACCINE
  1. MARKET BY TECHNOLOGY
    • LIVE ATTENUATED VACCINE
    • INACTIVATED VACCINE
    • RECOMBINANT VACCINE
    • TOXOID VACCINE
    • OTHER TECHNOLOGY
  2. MARKET BY DISEASE TYPE
    • CANINE DISEASE
    • PORCINE DISEASE
    • BOVINE DISEASE
    • POULTRY DISEASE
    • AQUACULTURE DISEASE
    • OTHER DISEASE TYPE

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now